AKTIS ONCOLOGY INC (AKTS) Stock Earnings Estimates

NASDAQ:AKTS • US01021M1045

19.67 USD
-0.33 (-1.65%)
Last: Feb 25, 2026, 11:48 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
AKTS revenue by date.AKTS revenue by date.
15.35M
131.87%

-100.00%
1.487M38.157M
2,466.04%
53.04M
39.00%
EBITDA
YoY % growth
AKTS ebitda by date.AKTS ebitda by date.
-60.115M
-63.67%
-33.674M
43.98%
-50.475M
-49.89%
N/AN/A
EBIT
YoY % growth
AKTS ebit by date.AKTS ebit by date.
-60.56M
-46.32%
-34.794M
42.55%
-52.05M
-49.59%
-35.981M
30.87%
-31.374M
12.81%
Operating Margin
AKTS operating margin by date.AKTS operating margin by date.
-394.53%N/A-3,500.34%-94.30%-59.15%
EPS
YoY % growth
AKTS eps by date.AKTS eps by date.
-0.96
2.04%
-0.88
8.33%
N/A
19.25%
-0.41
42.58%
-0.40
2.50%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.55
-390.91%
-0.11
-187.69%
-0.09
-3.84%
-0.09
-8.00%
-0.09
83.33%
Revenue
Q2Q % growth
3.366M
-42.51%
11.934M
32.20%
12.852M
39.54%
13.77M
197.60%
14.484M
330.30%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-19.278M
-23.30%
-10.762M
-101.69%
-8.564M
5.24%
-8.495M
85.18%
-8.815M
54.28%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth

39.29%
-0.08%
Q2 2025
Q2Q % growth

53.47%
-0.09%
Q1 2025
Q2Q % growth
-0.04
85.00%
-0.100.0660.45%
Q4 2024
Q2Q % growth

46.57%
-0.11%
Q3 2024
Q2Q % growth
-0.14
30.00%
-0.12-0.02-14.38%
Q2 2024
Q2Q % growth
-0.19 -0.18-0.01-3.49%
Q1 2024
Q2Q % growth
-0.26
7.14%
-0.18-0.08-41.61%
Q4 2023
Q2Q % growth
-0.21
19.23%
-0.17-0.04-24.03%
Q3 2023
Q2Q % growth
-0.20
9.09%
-0.200.00-2.12%
Q2 2023
Q2Q % growth
-0.19
17.39%
-0.260.0725.49%
Q1 2023
Q2Q % growth
-0.28
-12.00%
-0.21-0.07-35.56%
Q4 2022
Q2Q % growth
-0.26
-13.04%
-0.20-0.06-31.85%
Q3 2022
Q2Q % growth
-0.22 -0.220.001.96%
Q2 2022
Q2Q % growth
-0.23
-4.55%
-0.21-0.02-10.00%
Q1 2022
Q2Q % growth
-0.25
19.35%
-0.20-0.05-24.62%
Q4 2021
Q2Q % growth
-0.23
14.81%
-0.19-0.04-20.80%
Q3 2021
Q2Q % growth
-0.22
-4.76%
-0.280.0622.04%
Q2 2021
Q2Q % growth
-0.22
26.67%
-0.240.028.22%
Q1 2021
Q2Q % growth
-0.31
-3.33%
-0.23-0.08-34.48%
Q4 2020
Q2Q % growth
-0.27 -0.23-0.04-18.53%
Q3 2020
Q2Q % growth
-0.21 -0.250.0416.82%
Q2 2020
Q2Q % growth
-0.30 -0.27-0.03-13.12%
Q1 2020
Q2Q % growth
-0.30 -0.24-0.06-25.83%
AKTS Yearly EPS VS EstimatesAKTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
4.627M
-38.39%
10.349M-5.722M-55.29%
Q2 2025
Q2Q % growth

31.25%
9.21M%
Q1 2025
Q2Q % growth
9.027M
28.92%
8.188M839K10.25%
Q4 2024
Q2Q % growth
5.855M
-29.74%
7.469M-1.614M-21.61%
Q3 2024
Q2Q % growth
7.51M
2.09%
8.724M-1.214M-13.92%
Q2 2024
Q2Q % growth
7.017M
19.54%
7.128M-111K-1.56%
Q1 2024
Q2Q % growth
7.002M
25.71%
7.22M-218K-3.02%
Q4 2023
Q2Q % growth
8.333M
60.25%
8.608M-275K-3.19%
Q3 2023
Q2Q % growth
7.356M
59.57%
7.678M-322K-4.19%
Q2 2023
Q2Q % growth
5.87M
59.95%
6.038M-168K-2.78%
Q1 2023
Q2Q % growth
5.57M
197.86%
5.675M-105K-1.85%
Q4 2022
Q2Q % growth
5.2M
140.74%
6.306M-1.106M-17.54%
Q3 2022
Q2Q % growth
4.61M
82.94%
4.799M-189K-3.94%
Q2 2022
Q2Q % growth
3.67M
180.15%
3.854M-184K-4.77%
Q1 2022
Q2Q % growth
1.87M
192.19%
2.055M-185K-9.00%
Q4 2021
Q2Q % growth
2.16M
483.78%
2.553M-393K-15.39%
Q3 2021
Q2Q % growth
2.52M
600.00%
2.295M225K9.80%
Q2 2021
Q2Q % growth
1.31M
151.92%
1.042M268K25.72%
Q1 2021
Q2Q % growth
640K
18.52%
539.753K100.247K18.57%
Q4 2020
Q2Q % growth
370K 493.823K-123.823K-25.07%
Q3 2020
Q2Q % growth
360K 521.393K-161.393K-30.95%
Q2 2020
Q2Q % growth
520K 562.459K-42.459K-7.55%
Q1 2020
Q2Q % growth
540K 600.525K-60.525K-10.08%
AKTS Yearly Revenue VS EstimatesAKTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-575% -575% 0% 0%
Revenue-70.37% -70.37% 0% 0%